Market Research Logo

Global Novel Drug Delivery Systems Market Insights, Forecast to 2025

Global Novel Drug Delivery Systems Market Insights, Forecast to 2025

Summary

This report studies the global market size of Novel Drug Delivery Systems in key regions like North America, Europe, Asia Pacific, South America and the Middle East & Africa, focuses on the consumption of Novel Drug Delivery Systems in these regions.

This research report categorizes the global Novel Drug Delivery Systems market by top players/brands, region, type and end user. This report also studies the global Novel Drug Delivery Systems market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, channels and distributors.

In 2018, the global Novel Drug Delivery Systems market size was increased to 23728.57million US$ from 22421.84 million US$ in 2014, and it will reach 26582.04million US$ in 2025, growing at CAGR of 1.73% between 2019 and 2025.

The following manufacturers are covered in this report, with revenue, market share for each company:
Amgen
Teva
Roche
UCB (Union Chimique Belge)
Celgene
Merck
Gilead Sciences
Sanofi
Pfizer
Takeda
Bausch&Lomb
Samyang Biopharmaceuticals
Johnson & Johnson
TOLMAR
Astellas
AMAG Pharmaceuticals
AbbVie
Dr Reddy
AstraZeneca
Aspen
Acrotech Biopharma
TWi Pharmaceuticals

Novel Drug Delivery Systems market size by type:
Liposomes
PEGylated Proteins & Polypeptides
Polymer Nanoparticle
Protein¨Cdrug Conjugates
Other

Novel Drug Delivery Systems market size by Applications:
Hospitals & Clinic
Cancer Treatment Centers
Others

Novel Drug Delivery Systems market size by region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Europe
Germany
France
UK
Italy
Russia
Rest of Europe
South America
Brazil
Rest of South America
Middle East & Africa
Middle East
Africa


1 Study Coverage
1.1 Novel Drug Delivery Systems Product Introduction
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Novel Drug Delivery Systems Market Size Growth Rate by Type
1.4.2 Liposomes
1.4.3 PEGylated Proteins & Polypeptides
1.4.4 Polymer Nanoparticle
1.4.5 Protein¨Cdrug Conjugates
1.5 Market by Application
1.5.1 Global Novel Drug Delivery Systems Market Size Growth Rate by Application
1.5.2 Hospitals & Clinic
1.5.3 Cancer Treatment Centers
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Novel Drug Delivery Systems Market Size
2.2 Novel Drug Delivery Systems Growth Rate by Region
3 Breakdown Data by Manufacturer
3.1 Novel Drug Delivery Systems Revenue by Manufacturer
3.1.1 Novel Drug Delivery Systems Revenue by Manufacturer (2018-2019)
3.1.2 Novel Drug Delivery Systems Revenue Share by Manufacturer (2018-2019)
3.2 Global Market Concentration Ratio (CR5 and HHI)
3.3 Novel Drug Delivery Systems Gross Margin by Manufacturer
3.4 Novel Drug Delivery Systems Headquarters, Product Types
3.4.1 Novel Drug Delivery Systems Manufacturers Headquarters and Established Date
3.4.2 Manufacturers Novel Drug Delivery Systems Product Type
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Novel Drug Delivery Systems Revenue by Type
4.2 Global Novel Drug Delivery Systems Revenue Share by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Novel Drug Delivery Systems Breakdown Data by Application
6 North America
6.1 North America Novel Drug Delivery Systems by Country
6.1.1 North America Novel Drug Delivery Systems Revenue by Country
6.1.2 United States
6.1.3 Canada
6.1.4 Mexico
6.2 North America Novel Drug Delivery Systems by Type
6.3 North America Novel Drug Delivery Systems by Application
7 Europe
7.1 Europe Novel Drug Delivery Systems by Country
7.1.1 Europe Novel Drug Delivery Systems Revenue by Country
7.1.2 Germany
7.1.2 France
7.1.4 UK
7.1.5 Italy
7.1.6 Russia
7.2 Europe Novel Drug Delivery Systems by Type
7.3 Europe Novel Drug Delivery Systems by Application
8 Asia Pacific
8.1 Asia Pacific Novel Drug Delivery Systems by Country
8.1.1 Asia Pacific Novel Drug Delivery Systems Revenue by Country
8.1.2 China
8.1.3 Japan
8.1.4 Korea
8.1.5 India
8.1.7 Southeast Asia
8.2 Asia Pacific Novel Drug Delivery Systems by Type
8.3 Asia Pacific Novel Drug Delivery Systems by Application
9 South America
9.1 South America Novel Drug Delivery Systems by Country
9.1.1 South America Novel Drug Delivery Systems Revenue by Country
9.1.2 Brazil
9.1.3 Argentina
9.2 South America Novel Drug Delivery Systems by Type
9.3 South America Novel Drug Delivery Systems by Application
10 Middle East and Africa
10.1 Middle East and Africa Novel Drug Delivery Systems by Country
10.1.1 Middle East and Africa Novel Drug Delivery Systems Revenue by Country
10.1.1 Middle East
10.1.2 Africa
10.2 Middle East and Africa Novel Drug Delivery Systems by Type
10.3 Middle East and Africa Novel Drug Delivery Systems by Application
11 Analysis of Novel Drug Delivery Systems Industry Key Manufacturers
11.1 Amgen
11.1.1 Company Profile
11.1.2 Product Information
11.1.3 Revenue, Gross Margin and Market Share
11.2 Teva
11.2.1 Company Profile
11.2.2 Product Information
11.2.3 Revenue, Gross Margin and Market Share
11.3 Roche
11.3.1 Company Profile
11.3.2 Product Information
11.3.3 Revenue, Gross Margin and Market Share
11.4 UCB (Union Chimique Belge)
11.4.1 Company Profile
11.4.2 Product Information
11.4.3 Revenue, Gross Margin and Market Share
11.5 Celgene
11.5.1 Company Profile
11.5.2 Product Information
11.5.3 Revenue, Gross Margin and Market Share
11.6 Merck
11.6.1 Company Profile
11.6.2 Product Information
11.6.3 Revenue, Gross Margin and Market Share
11.7 Gilead Sciences
11.7.1 Company Profile
11.7.2 Product Information
11.7.3 Revenue, Gross Margin and Market Share
11.8 Sanofi
11.8.1 Company Profile
11.8.2 Product Information
11.8.3 Revenue, Gross Margin and Market Share
11.9 Pfizer
11.9.1 Company Profile
11.9.2 Product Information
11.9.3 Revenue, Gross Margin and Market Share
11.10 Takeda
11.10.1 Company Profile
11.10.2 Product Information
11.10.3 Revenue, Gross Margin and Market Share
11.11 Bausch&Lomb
11.11.1 Company Profile
11.11.2 Product Information
11.11.3 Revenue, Gross Margin and Market Share
11.12 Samyang Biopharmaceuticals
11.12.1 Company Profile
11.12.2 Product Information
11.12.3 Revenue, Gross Margin and Market Share
11.13 Johnson & Johnson
11.13.1 Company Profile
11.13.2 Product Information
11.13.3 Revenue, Gross Margin and Market Share
11.14 TOLMAR
11.14.1 Company Profile
11.14.2 Product Information
11.14.3 Revenue, Gross Margin and Market Share
11.15 Astellas
11.15.1 Company Profile
11.15.2 Product Information
11.15.3 Revenue, Gross Margin and Market Share
11.16 AMAG Pharmaceuticals
11.16.1 Company Profile
11.16.2 Product Information
11.16.3 Revenue, Gross Margin and Market Share
11.17 AbbVie
11.17.1 Company Profile
11.17.2 Product Information
11.17.3 Revenue, Gross Margin and Market Share
11.18 Dr Reddy
11.18.1 Company Profile
11.18.2 Product Information
11.18.3 Revenue, Gross Margin and Market Share
11.19 AstraZeneca
11.19.1 Company Profile
11.19.2 Product Information
11.19.3 Revenue, Gross Margin and Market Share
11.20 Aspen
11.20.1 Company Profile
11.20.2 Product Information
11.20.3 Revenue, Gross Margin and Market Share
11.21 Acrotech Biopharma
11.21.1 Company Profile
11.21.2 Product Information
11.21.3 Revenue, Gross Margin and Market Share
11.22 TWi Pharmaceuticals
11.22.1 Company Profile
11.22.2 Product Information
11.22.3 Revenue, Gross Margin and Market Share
12 Future Forecast
12.1 Novel Drug Delivery Systems Market Forecast by Region
12.2 Novel Drug Delivery Systems Market Forecast by Type
12.3 Novel Drug Delivery Systems Market Forecast by Application
12.4 North America Novel Drug Delivery Systems Forecast
12.5 Europe Novel Drug Delivery Systems Forecast
12.6 Asia Pacific Novel Drug Delivery Systems Forecast
12.7 South America Novel Drug Delivery Systems Forecast
12.8 Middle East and Africa Novel Drug Delivery Systems Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter¡¯s Five Forces Analysis
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Novel Drug Delivery Systems Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Novel Drug Delivery Systems Product Picture
Table Novel Drug Delivery Systems Market Segments
Table Key Manufacturers of Novel Drug Delivery Systems Covered in 2018
Table Global Novel Drug Delivery Systems Market Size Growth Rate by Type (2019-2025) (Million US$)
Figure Global Novel Drug Delivery Systems Market Share by Type in 2018
Figure Global Novel Drug Delivery Systems Market Share by Type in 2025
Figure Liposomes Product Picture
Figure PEGylated Proteins & Polypeptides Product Picture
Figure Polymer Nanoparticle Product Picture
Figure Protein¨Cdrug Conjugates Product Picture
Table Global Novel Drug Delivery Systems Market Size Growth Rate by Application (2019-2025) (Million US$)
Figure Global Novel Drug Delivery Systems Market Share by Application in 2018
Figure Global Novel Drug Delivery Systems Market Share by Application in 2025
Figure Hospitals & Clinic
Figure Cancer Treatment Centers
Figure Novel Drug Delivery Systems Report Years Considered
Figure Global Novel Drug Delivery Systems Market Size 2014-2025 (Million US$)
Table Global Novel Drug Delivery Systems Market Size by Region 2019-2025 (Million US$)
Figure Global Novel Drug Delivery Systems Market Share by Regions in 2018
Table Global Novel Drug Delivery Systems Revenue by Region 2014-2019 (Million US$)
Figure Global Novel Drug Delivery Systems Revenue Market Share by Region 2014-2019
Figure Global Novel Drug Delivery Systems Revenue Market Share by Region in 2018
Table Novel Drug Delivery Systems Revenue by Manufacturer (2018-2019) (Million USD)
Table Novel Drug Delivery Systems Revenue Share by Manufacturer (2018-2019)
Figure Novel Drug Delivery Systems Revenue Share by Manufacturer in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Novel Drug Delivery Systems Gross Margin (2018-2019)
Table Novel Drug Delivery Systems Manufacturers Headquarters and Established Date
Table Manufacturers Novel Drug Delivery Systems Product Type
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Novel Drug Delivery Systems Revenue by Type (2014-2019) (Million US$)
Figure Global Novel Drug Delivery Systems Revenue Market Share by Type (2014-2019)
Figure Global Novel Drug Delivery Systems Revenue Market Share by Type in 2018
Table Global Novel Drug Delivery Systems Market Size Growth Rate by Application (2019-2025) (Million US$)
Table Global Novel Drug Delivery Systems Revenue by Application (2014-2019) (Million US$)
Table Global Novel Drug Delivery Systems Revenue Share by Application (2014-2019)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report